FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

708822004: Secukinumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2015. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3037500017 Secukinumab en Synonym Active Entire term case insensitive SNOMED CT core module
3037626016 Secukinumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Secukinumab Is a Immunosuppressant true Inferred relationship Existential restriction modifier
Secukinumab Is a Monoclonal antibody agent false Inferred relationship Existential restriction modifier
Secukinumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Secukinumab Has disposition Immunomodulator true Inferred relationship Existential restriction modifier
Secukinumab Is a Murine-human monoclonal immunoglobulin G antibody false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing secukinumab Has active ingredient True Secukinumab Inferred relationship Existential restriction modifier 1
Secukinumab Has active ingredient True Secukinumab Inferred relationship Existential restriction modifier 1
Product containing secukinumab in parenteral dose form (medicinal product form) Has active ingredient True Secukinumab Inferred relationship Existential restriction modifier 1
Product containing only secukinumab in parenteral dose form (medicinal product form) Has active ingredient True Secukinumab Inferred relationship Existential restriction modifier 1
Secukinumab therapy Direct substance True Secukinumab Inferred relationship Existential restriction modifier 1
Product containing precisely secukinumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Secukinumab Inferred relationship Existential restriction modifier 1
Product containing precisely secukinumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Secukinumab Inferred relationship Existential restriction modifier 1
Secukinumab 150mg/1ml solution for injection pre-filled disposable devices Has active ingredient False Secukinumab Inferred relationship Existential restriction modifier
Secukinumab 75mg/0.5ml solution for injection pre-filled syringes Has specific active ingredient True Secukinumab Inferred relationship Existential restriction modifier
Secukinumab 75mg/0.5ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Secukinumab Inferred relationship Existential restriction modifier
Cosentyx 75mg/0.5ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) 1 pre-filled disposable injection Has specific active ingredient True Secukinumab Inferred relationship Existential restriction modifier
Cosentyx 75mg/0.5ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Secukinumab Inferred relationship Existential restriction modifier
Secukinumab 150mg/1ml solution for injection pre-filled syringes Has active ingredient False Secukinumab Inferred relationship Existential restriction modifier
Secukinumab 300mg/2ml solution for injection pre-filled disposable devices Has specific active ingredient True Secukinumab Inferred relationship Existential restriction modifier
Cosentyx 300mg/2ml solution for injection pre-filled pens (Novartis Pharmaceuticals UK Ltd) 1 pre-filled disposable injection Has specific active ingredient True Secukinumab Inferred relationship Existential restriction modifier
Secukinumab 300mg/2ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection Has specific active ingredient True Secukinumab Inferred relationship Existential restriction modifier
Cosentyx 300mg/2ml solution for injection pre-filled pens (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Secukinumab Inferred relationship Existential restriction modifier
Secukinumab 150mg/1ml solution for injection pre-filled disposable devices Has specific active ingredient True Secukinumab Inferred relationship Existential restriction modifier
Secukinumab 150mg/1ml solution for injection pre-filled syringes Has specific active ingredient True Secukinumab Inferred relationship Existential restriction modifier
Cosentyx 150mg/1ml solution for injection pre-filled pens (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Secukinumab Inferred relationship Existential restriction modifier
Cosentyx 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient False Secukinumab Inferred relationship Existential restriction modifier
Secukinumab 150mg/1ml solution for injection pre-filled syringes 2 pre-filled disposable injection Has specific active ingredient True Secukinumab Inferred relationship Existential restriction modifier
Secukinumab 150mg/1ml solution for injection pre-filled disposable devices 2 pre-filled disposable injection Has specific active ingredient True Secukinumab Inferred relationship Existential restriction modifier
Cosentyx 150mg/1ml solution for injection pre-filled pens (Novartis Pharmaceuticals UK Ltd) 2 pre-filled disposable injection Has specific active ingredient True Secukinumab Inferred relationship Existential restriction modifier
Cosentyx 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) 2 pre-filled disposable injection Has specific active ingredient False Secukinumab Inferred relationship Existential restriction modifier
Cosentyx 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Secukinumab Inferred relationship Existential restriction modifier
Cosentyx 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) 2 pre-filled disposable injection Has specific active ingredient True Secukinumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start